Marshall Wace
PHVS icon

Marshall Wace’s Pharvaris PHVS Stock Holding History

Marshall Wace’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,832
Closed -$883K – 3574
2025
Q4 		$883K Buy
31,832
+4,736
+17% +$114K ﹤0.01% 1998
2025
Q3 		$676K Buy
+27,096
New +$601K ﹤0.01% 2117
2024
Q4 		– Sell
-59,014
Closed -$1.09M – 2914
2024
Q3 		$1.09M Buy
59,014
+7,846
+15% +$143K ﹤0.01% 1621
2024
Q2 		$962K Sell
51,168
-7,001
-12% -$142K ﹤0.01% 1710
2024
Q1 		$1.34M Sell
58,169
-1,955
-3% -$51.9K ﹤0.01% 1532
2023
Q4 		$1.69M Buy
+60,124
New +$1.22M ﹤0.01% 1291

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Marshall Wace's PHVS Position: Q1 2026 in Review

Marshall Wace sold out of Pharvaris (PHVS) in Q1 2026, closing a stake of 31,832 shares — an estimated $883K sold.

Marshall Wace first reported a position in PHVS in Q4 2023 and held it in 6 quarters. The position peaked at $1.69M in Q4 2023. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Marshall Wace reported no remaining Pharvaris position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 31,832 Pharvaris shares in Q1 2026, an estimated $883K.
  • Marshall Wace first reported a position in Pharvaris in Q4 2023 and held it in 6 quarters.
  • Marshall Wace's Pharvaris position peaked at $1.69M in Q4 2023.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.